[go: up one dir, main page]

AU2001229320A1 - Inhibitors of prenyl-protein transferase - Google Patents

Inhibitors of prenyl-protein transferase

Info

Publication number
AU2001229320A1
AU2001229320A1 AU2001229320A AU2932001A AU2001229320A1 AU 2001229320 A1 AU2001229320 A1 AU 2001229320A1 AU 2001229320 A AU2001229320 A AU 2001229320A AU 2932001 A AU2932001 A AU 2932001A AU 2001229320 A1 AU2001229320 A1 AU 2001229320A1
Authority
AU
Australia
Prior art keywords
prenyl
inhibitors
protein transferase
transferase
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001229320A
Inventor
S. Jane Desolms
Suzanne C. Mactough
Anthony W. Shaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU2001229320A1 publication Critical patent/AU2001229320A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D419/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2001229320A 2000-01-12 2001-01-09 Inhibitors of prenyl-protein transferase Abandoned AU2001229320A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17578400P 2000-01-12 2000-01-12
US60175784 2000-01-12
PCT/US2001/000633 WO2001051126A1 (en) 2000-01-12 2001-01-09 Inhibitors of prenyl-protein transferase

Publications (1)

Publication Number Publication Date
AU2001229320A1 true AU2001229320A1 (en) 2001-07-24

Family

ID=22641611

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001229320A Abandoned AU2001229320A1 (en) 2000-01-12 2001-01-09 Inhibitors of prenyl-protein transferase

Country Status (3)

Country Link
US (1) US6525074B2 (en)
AU (1) AU2001229320A1 (en)
WO (1) WO2001051126A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4673833B2 (en) * 2003-01-07 2011-04-20 メルク・シャープ・エンド・ドーム・コーポレイション Macrocyclic β-secretase inhibitor for the treatment of Alzheimer's disease
CA2528375C (en) 2003-06-18 2013-11-19 Tranzyme Pharma, Inc. Macrocyclic antagonists of the motilin receptor
US20050154451A1 (en) * 2003-12-18 2005-07-14 Medtronic Vascular, Inc. Medical devices to treat or inhibit restenosis
JP4917021B2 (en) * 2004-05-03 2012-04-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Diastereoselective addition of lithiated N-methylimidazole to sulfimines
CA2563806C (en) * 2004-05-03 2012-11-20 Janssen Pharmaceutica N.V. Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinoline
WO2006055434A2 (en) * 2004-11-17 2006-05-26 Merck & Co., Inc. Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease
JP2008520727A (en) * 2004-11-23 2008-06-19 メルク エンド カムパニー インコーポレーテッド Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of Alzheimer's disease
US7888376B2 (en) * 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5719148A (en) 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
US5721236A (en) 1993-10-15 1998-02-24 Schering Corporation Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5891872A (en) 1995-04-07 1999-04-06 Schering Corporation Tricyclic compounds
US5801175A (en) 1995-04-07 1998-09-01 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5712280A (en) 1995-04-07 1998-01-27 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5756528A (en) 1995-06-06 1998-05-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5968965A (en) 1996-01-30 1999-10-19 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
JP2000504017A (en) 1996-01-30 2000-04-04 メルク エンド カンパニー インコーポレーテッド Farnesyl-protein transferase inhibitor
US5981562A (en) 1996-01-30 1999-11-09 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6028201A (en) 1996-01-30 2000-02-22 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5922883A (en) 1996-04-03 1999-07-13 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5780488A (en) 1996-04-03 1998-07-14 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
JP2001500515A (en) 1996-09-13 2001-01-16 シェーリング コーポレイション Compounds useful for inhibiting farnesyl protein transferase
JP2002519428A (en) 1998-07-02 2002-07-02 メルク エンド カムパニー インコーポレーテッド Inhibitors of prenyl-protein transferase
AU760028B2 (en) 1998-07-02 2003-05-08 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
EP1091736A4 (en) 1998-07-02 2001-10-24 Merck & Co Inc Inhibitors of prenyl-protein transferase

Also Published As

Publication number Publication date
US20020049217A1 (en) 2002-04-25
US6525074B2 (en) 2003-02-25
WO2001051126A1 (en) 2001-07-19

Similar Documents

Publication Publication Date Title
AU2001243158A1 (en) Inhibitors of prenyl-protein transferase
AU2001241927A1 (en) Inhibitors of p38-alpha kinase
AU2001237041A1 (en) Kinase inhibitors
AU2001258771A1 (en) -secretase inhibitors
AU2001238217A1 (en) Inhibitors of prenyl-protein transferase
EP1091736A4 (en) Inhibitors of prenyl-protein transferase
AU2001247197A1 (en) Inhibitors of prenyl-protein transferase
AU7354900A (en) Inhibitors of prenyl-protein transferase
AU2477400A (en) Inhibitors of prenyl-protein transferase
AU2001227757A1 (en) Inhibitors of prenyl-protein transferase
AU2002237657A1 (en) Indole-type inhibitors of p38 kinase
AU2001253197A1 (en) Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase
AU2001238424A1 (en) Inhibitors of prenyl-protein transferase
AU2002211662A1 (en) Nf-kappab inhibitors
AU2274101A (en) Inhibitors of prenyl-protein transferase
AU2001255090A1 (en) Cdk inhibitors having 3-hydroxychromen-4-one structure
AU2001230864A1 (en) Inhibitors of prenyl-protein transferase
AU2001229320A1 (en) Inhibitors of prenyl-protein transferase
AU2002214038A1 (en) Inhibitors of transglutaminases
AU2001227756A1 (en) Inhibitors of prenyl-protein transferase
AU2002254375A1 (en) Inhibitors of prenyl-protein transferase
AU2001251445A1 (en) Inhibitors of prenyl-protein transferase
AU2478500A (en) Inhibitors of prenyl-protein transferase
AU2001273010A1 (en) Inhibitors of prenyl-protein transferase
AU2001227755A1 (en) Inhibitors of prenyl-protein transferase